Wooden bear, that is the question that we don't have an answer to that will complete the story. IMHO the study has not been unblinded and Tony C is cautious to insure alignment with FDA and not jump the gun. It appears that they are packing what was supposed to be in two meetings with the FDA into one on Oct. 17. This is where I seriously would have a hard time staying in without Tony's experience. He knows the FDA process well. This will be clarified at the annual meeting this week. Things are getting exciting.
News 
Market Data 
Discover 
